Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Endometriosis (Disease Or Phenotype)

Omim:MTHU036719

Nci:C3014

Msh:D004715

Mondo:MONDO:5133

Medcin:MEDCIN:30610

Mdr:MDR:10087669

Id:7c4663ca-c442-5a37-93f1-60b0b36c153d

Icpc2icd10eng:MTHU026111

Icd10cm:N80.9

Efo:EFO:1065

Doid:DOID:289

Chv:CHV:4463

Results found

Linked to

	Label	Description
	Chlormadinone indication Endometriosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	progesterone indication Endometriosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1-{4-[1-(2,6-Difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea indication Endometriosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Norethynodrel indication Endometriosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Medroxyprogesterone indication Endometriosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Danazol indication Endometriosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Leuprolide indication Endometriosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	norethindrone indication Endometriosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	elagolix indication Endometriosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Nafarelin indication Endometriosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Chlormadinone indication Endometriosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

progesterone indication Endometriosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

1-{4-[1-(2,6-Difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea indication Endometriosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Norethynodrel indication Endometriosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Medroxyprogesterone indication Endometriosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Danazol indication Endometriosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Leuprolide indication Endometriosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

norethindrone indication Endometriosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

elagolix indication Endometriosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Nafarelin indication Endometriosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.